Literature DB >> 30041967

Resection for anal melanoma: Is there an optimal approach?

Molly M Ford1, Rondi M Kauffmann2, Timothy M Geiger3, M Benjamin Hopkins3, Roberta L Muldoon3, Alexander T Hawkins3.   

Abstract

BACKGROUND: Anal melanoma is a lethal disease, but its rarity makes understanding the behavior and effects of intervention challenging. Local resection and abdominal perineal resection are the proposed treatments for nonmetastatic disease. We hypothesize that there is no difference in overall survival between surgical therapies.
METHODS: The National Cancer Database (2004-2014) was queried for adults with a diagnosis of anal melanoma who underwent curative resection. Patients with metastatic disease were excluded. Patients were divided into 2 groups based on surgical approach (local resection versus abdominal perineal resection). Unadjusted and adjusted analyses were used to examine the association between surgical approach and R0 resection rate, short-term survival, and overall survival.
RESULTS: A total of 570 patients with anal melanoma who underwent resection were identified. The median age was 68 and 59% of patients were female. A total of 383 (67%) underwent local resection. Abdominal perineal resection was associated with higher rates of R0 resection rates (abdominal perineal resection 91% versus local resection 73%; P < .001). Overall 5-year survival for the entire cohort was 20%. There was no significant difference in 5-year overall survival (abdominal perineal resection 21% vs local resection 17%; P = .31). This persisted in a Cox proportional hazard multivariable model (odds ratio 0.84; 95% confidence interval 0.66-1.06; P = .15). Additionally, there was no improvement in overall survival for patients who underwent R0 resection (odds ratio 1.18; 95% confidence interval 0.90-1.56; P = .22).
CONCLUSION: Anal melanoma has a very poor prognosis, with only 1 of 5 patients alive at 5 years. Although local resection was associated with lower rates of R0 resection, there was no discernable difference in overall survival in both unadjusted and adjusted analysis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30041967     DOI: 10.1016/j.surg.2018.05.026

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Anorectal Mucosal Melanoma in the Era of Immune Checkpoint Inhibition: Should We Change Our Surgical Management Paradigm?

Authors:  Mohammad Adileh; Jonathan B Yuval; Shan Huang; Alexander N Shoushtari; Felipe Quezada-Diaz; Emmanouil P Pappou; Martin R Weiser; Julio Garcia-Aguilar; J Joshua Smith; Philip B Paty; Garrett M Nash
Journal:  Dis Colon Rectum       Date:  2021-05       Impact factor: 4.585

2.  Difficulties in diagnosing anorectal melanoma: A case report and review of the literature.

Authors:  Raluca Cristina Apostu; Elena Stefanescu; Radu Razvan Scurtu; Gabriel Kacso; Radu Drasovean
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

3.  Extensive resection improves overall and disease-specific survival in localized anorectal melanoma: A SEER-based study.

Authors:  Chang Liu; Cuiping Tang; Jianbo Zhang; Peng Zhu
Journal:  Front Surg       Date:  2022-08-30

4.  Surgical treatment of anorectal melanoma: a systematic review and meta-analysis.

Authors:  Esther Jutten; Schelto Kruijff; Anne Brecht Francken; Martijn F Lutke Holzik; Barbara L van Leeuwen; Henderik L van Westreenen; Kevin P Wevers
Journal:  BJS Open       Date:  2021-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.